April 1, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in April

Read More
April 1, 2022

Yescarta Granted Approval for Earlier Use in B-Cell Lymphoma

Read More
April 1, 2022

Triumeq PD Approved to Treat HIV

Read More
March 30, 2022

Edurant and Vocabria Now Approved for Pediatric Patients

Read More
March 30, 2022

Cabenuva Approved for Children, No Longer Requires Lead-In Therapy

Read More
March 29, 2022

Teva Recalls One Lot of Leukemia Medication

Read More
March 29, 2022

Higher Ozempic Dose Available to Improve Blood Sugar Control

Read More
March 29, 2022

Comirnaty and Spikevax Authorized for Second Booster Shots

Read More
March 28, 2022

FDA Approves Fintepla Use in Broader Patient Population

Read More
March 23, 2022

FDA Approves Novel Radioactive Agent to Treat Prostate Cancer

Read More
March 22, 2022

Two Manufacturers Recall Drugs After Finding Nitrosamine Impurities

Read More
March 22, 2022

Symjepi Needle May Clog, Leading to Recall of Four Lots

Read More